Longitudinal flortaucipir ([18F]AV-1451) PET imaging in primary progressive apraxia of speech

Rene L. Utianski, Peter R. Martin, Hugo Botha, Christopher G. Schwarz, Joseph R. Duffy, Ronald C. Petersen, David S. Knopman, Heather M. Clark, Alissa M. Butts, Mary M. Machulda, Clifford R. Jack, Val J. Lowe, Jennifer L. Whitwell, Keith A. Josephs

Research output: Contribution to journalArticle

Abstract

Primary progressive apraxia of speech (PPAOS) is a term used to describe a neurodegenerative condition in which apraxia of speech (AOS; a planning and/or programming deficit) occurs in the absence of aphasia (a language deficit). PPAOS is strongly associated with 4-repeat tau pathology. Elevated flortaucipir ([18F]AV-1451; FTP) uptake has been observed cross-sectionally in patients with PPAOS and those with aphasia. Here, we evaluated longitudinal changes in previously-identified regions of uptake and their relationship with clinical presentation. Thirteen patients who were diagnosed with PPAOS (5 female) at presentation underwent FTP PET imaging at two visits (mean 1 year interval). Median age was 72, with a median of 4 years disease duration at initial testing. Beta-amyloid status was assessed with Pittsburgh Compound B (PiB), where a global PiB ratio>1.48 was deemed amyloid positive (n = 4). FTP uptake was assessed as cortical to cerebellar crus ratios (SUVr) in cortical regions of interest. A single hierarchical linear model (HLM) compared PPAOS patients to 52 cognitively unimpaired controls of similar age and sex. Annualized SUVr change was the outcome, predicted by region, clinical status, and age. Person-specific effects accounted for intra-patient correlations and contralateral regions were included as repeated measures. Changes in clinical measures were assessed using Wilcoxon signed-rank tests; statistically significant changes in the Montreal Cognitive Assessment, MDS-UPDRS, motor section, and PSP Rating Scale were noted between visits. Changes in FTP SUVr were greater for patients than controls. The strongest changes in PPAOS patients were in the precentral gyrus, pallidum, and mid and superior frontal gyri, per the HLM. Qualitatively, larger changes were seen in patients who had developed aphasia by the time of their baseline scan (n = 5). While the biological mechanisms of FTP signal in non-AD tauopathies are unknown, this study demonstrates the utility of FTP in tracking disease progression in 4R tauopathies.

Original languageEnglish (US)
Pages (from-to)33-43
Number of pages11
JournalCortex
Volume124
DOIs
StatePublished - Mar 2020

Fingerprint

Apraxias
Aphasia
Tauopathies
Amyloid
Linear Models
Globus Pallidus
Frontal Lobe
Nonparametric Statistics
Prefrontal Cortex
Disease Progression
formycin triphosphate
Language
Pathology

Keywords

  • Aphasia
  • Apraxia of speech
  • Longitudinal
  • PET
  • Tauopathy

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology
  • Experimental and Cognitive Psychology
  • Cognitive Neuroscience

Cite this

Longitudinal flortaucipir ([18F]AV-1451) PET imaging in primary progressive apraxia of speech. / Utianski, Rene L.; Martin, Peter R.; Botha, Hugo; Schwarz, Christopher G.; Duffy, Joseph R.; Petersen, Ronald C.; Knopman, David S.; Clark, Heather M.; Butts, Alissa M.; Machulda, Mary M.; Jack, Clifford R.; Lowe, Val J.; Whitwell, Jennifer L.; Josephs, Keith A.

In: Cortex, Vol. 124, 03.2020, p. 33-43.

Research output: Contribution to journalArticle

@article{eb8eeac61dd74540a55c8aebd67e3ede,
title = "Longitudinal flortaucipir ([18F]AV-1451) PET imaging in primary progressive apraxia of speech",
abstract = "Primary progressive apraxia of speech (PPAOS) is a term used to describe a neurodegenerative condition in which apraxia of speech (AOS; a planning and/or programming deficit) occurs in the absence of aphasia (a language deficit). PPAOS is strongly associated with 4-repeat tau pathology. Elevated flortaucipir ([18F]AV-1451; FTP) uptake has been observed cross-sectionally in patients with PPAOS and those with aphasia. Here, we evaluated longitudinal changes in previously-identified regions of uptake and their relationship with clinical presentation. Thirteen patients who were diagnosed with PPAOS (5 female) at presentation underwent FTP PET imaging at two visits (mean 1 year interval). Median age was 72, with a median of 4 years disease duration at initial testing. Beta-amyloid status was assessed with Pittsburgh Compound B (PiB), where a global PiB ratio>1.48 was deemed amyloid positive (n = 4). FTP uptake was assessed as cortical to cerebellar crus ratios (SUVr) in cortical regions of interest. A single hierarchical linear model (HLM) compared PPAOS patients to 52 cognitively unimpaired controls of similar age and sex. Annualized SUVr change was the outcome, predicted by region, clinical status, and age. Person-specific effects accounted for intra-patient correlations and contralateral regions were included as repeated measures. Changes in clinical measures were assessed using Wilcoxon signed-rank tests; statistically significant changes in the Montreal Cognitive Assessment, MDS-UPDRS, motor section, and PSP Rating Scale were noted between visits. Changes in FTP SUVr were greater for patients than controls. The strongest changes in PPAOS patients were in the precentral gyrus, pallidum, and mid and superior frontal gyri, per the HLM. Qualitatively, larger changes were seen in patients who had developed aphasia by the time of their baseline scan (n = 5). While the biological mechanisms of FTP signal in non-AD tauopathies are unknown, this study demonstrates the utility of FTP in tracking disease progression in 4R tauopathies.",
keywords = "Aphasia, Apraxia of speech, Longitudinal, PET, Tauopathy",
author = "Utianski, {Rene L.} and Martin, {Peter R.} and Hugo Botha and Schwarz, {Christopher G.} and Duffy, {Joseph R.} and Petersen, {Ronald C.} and Knopman, {David S.} and Clark, {Heather M.} and Butts, {Alissa M.} and Machulda, {Mary M.} and Jack, {Clifford R.} and Lowe, {Val J.} and Whitwell, {Jennifer L.} and Josephs, {Keith A.}",
year = "2020",
month = "3",
doi = "10.1016/j.cortex.2019.11.002",
language = "English (US)",
volume = "124",
pages = "33--43",
journal = "Cortex",
issn = "0010-9452",
publisher = "Masson SpA",

}

TY - JOUR

T1 - Longitudinal flortaucipir ([18F]AV-1451) PET imaging in primary progressive apraxia of speech

AU - Utianski, Rene L.

AU - Martin, Peter R.

AU - Botha, Hugo

AU - Schwarz, Christopher G.

AU - Duffy, Joseph R.

AU - Petersen, Ronald C.

AU - Knopman, David S.

AU - Clark, Heather M.

AU - Butts, Alissa M.

AU - Machulda, Mary M.

AU - Jack, Clifford R.

AU - Lowe, Val J.

AU - Whitwell, Jennifer L.

AU - Josephs, Keith A.

PY - 2020/3

Y1 - 2020/3

N2 - Primary progressive apraxia of speech (PPAOS) is a term used to describe a neurodegenerative condition in which apraxia of speech (AOS; a planning and/or programming deficit) occurs in the absence of aphasia (a language deficit). PPAOS is strongly associated with 4-repeat tau pathology. Elevated flortaucipir ([18F]AV-1451; FTP) uptake has been observed cross-sectionally in patients with PPAOS and those with aphasia. Here, we evaluated longitudinal changes in previously-identified regions of uptake and their relationship with clinical presentation. Thirteen patients who were diagnosed with PPAOS (5 female) at presentation underwent FTP PET imaging at two visits (mean 1 year interval). Median age was 72, with a median of 4 years disease duration at initial testing. Beta-amyloid status was assessed with Pittsburgh Compound B (PiB), where a global PiB ratio>1.48 was deemed amyloid positive (n = 4). FTP uptake was assessed as cortical to cerebellar crus ratios (SUVr) in cortical regions of interest. A single hierarchical linear model (HLM) compared PPAOS patients to 52 cognitively unimpaired controls of similar age and sex. Annualized SUVr change was the outcome, predicted by region, clinical status, and age. Person-specific effects accounted for intra-patient correlations and contralateral regions were included as repeated measures. Changes in clinical measures were assessed using Wilcoxon signed-rank tests; statistically significant changes in the Montreal Cognitive Assessment, MDS-UPDRS, motor section, and PSP Rating Scale were noted between visits. Changes in FTP SUVr were greater for patients than controls. The strongest changes in PPAOS patients were in the precentral gyrus, pallidum, and mid and superior frontal gyri, per the HLM. Qualitatively, larger changes were seen in patients who had developed aphasia by the time of their baseline scan (n = 5). While the biological mechanisms of FTP signal in non-AD tauopathies are unknown, this study demonstrates the utility of FTP in tracking disease progression in 4R tauopathies.

AB - Primary progressive apraxia of speech (PPAOS) is a term used to describe a neurodegenerative condition in which apraxia of speech (AOS; a planning and/or programming deficit) occurs in the absence of aphasia (a language deficit). PPAOS is strongly associated with 4-repeat tau pathology. Elevated flortaucipir ([18F]AV-1451; FTP) uptake has been observed cross-sectionally in patients with PPAOS and those with aphasia. Here, we evaluated longitudinal changes in previously-identified regions of uptake and their relationship with clinical presentation. Thirteen patients who were diagnosed with PPAOS (5 female) at presentation underwent FTP PET imaging at two visits (mean 1 year interval). Median age was 72, with a median of 4 years disease duration at initial testing. Beta-amyloid status was assessed with Pittsburgh Compound B (PiB), where a global PiB ratio>1.48 was deemed amyloid positive (n = 4). FTP uptake was assessed as cortical to cerebellar crus ratios (SUVr) in cortical regions of interest. A single hierarchical linear model (HLM) compared PPAOS patients to 52 cognitively unimpaired controls of similar age and sex. Annualized SUVr change was the outcome, predicted by region, clinical status, and age. Person-specific effects accounted for intra-patient correlations and contralateral regions were included as repeated measures. Changes in clinical measures were assessed using Wilcoxon signed-rank tests; statistically significant changes in the Montreal Cognitive Assessment, MDS-UPDRS, motor section, and PSP Rating Scale were noted between visits. Changes in FTP SUVr were greater for patients than controls. The strongest changes in PPAOS patients were in the precentral gyrus, pallidum, and mid and superior frontal gyri, per the HLM. Qualitatively, larger changes were seen in patients who had developed aphasia by the time of their baseline scan (n = 5). While the biological mechanisms of FTP signal in non-AD tauopathies are unknown, this study demonstrates the utility of FTP in tracking disease progression in 4R tauopathies.

KW - Aphasia

KW - Apraxia of speech

KW - Longitudinal

KW - PET

KW - Tauopathy

UR - http://www.scopus.com/inward/record.url?scp=85076018927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076018927&partnerID=8YFLogxK

U2 - 10.1016/j.cortex.2019.11.002

DO - 10.1016/j.cortex.2019.11.002

M3 - Article

C2 - 31830664

AN - SCOPUS:85076018927

VL - 124

SP - 33

EP - 43

JO - Cortex

JF - Cortex

SN - 0010-9452

ER -